We recently demonstrated an Hsp90 small molecule inhibitor could be tethered to a near infrared (nIR) probe (HS131), and would specifically accumulate in all molecular subtypes of BC in vitro and in vivo20. This evidence concerns the gene HSP90AA1 and breast cancer.